Company page
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a public company traded on the American stock market under the ticker REGN. The company has a market capitalization of approximately $68.8 billion. Regeneron focuses on developing and commercializing innovative medicines for serious diseases.
- Ticker
- REGN:NASDAQ
- Asset type
- Stock
- Market cap
- $85.87B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD